HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive

ANDS: Anadys Pharmaceuticals Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
ANADYS PHARMACEUTICALS INC (NASD)
ANDS 2.19 0.00 (0.00%) Vol.  0 0.00 CST

Nov 03, 2009 Anadys Pharma (ANDS) Upgrade Alert, Watch for 8.5% Technical Downtrend Reversal
Nov 03, 2009 Analyst Upgrades for November 3rd
Nov 02, 2009 Anadys Pharmaceuticals Down 7% Since SmarTrend's Sell Recommendation
Oct 29, 2009 Anadys Pharmaceuticals Reports Third Quarter 2009 Financial Results and Program Highlights
Oct 29, 2009 Conference Calls Today: 5-5:30 P.M. EDT
Oct 28, 2009 Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Oct 22, 2009 Anadys Pharmaceuticals to Report Third Quarter 2009 Financial Results
Oct 20, 2009 Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
Sep 28, 2009 Anadys Pharmaceuticals to present at the JMP Securities Healthcare Focus Conference
Sep 26, 2009 Mid-Stage Study for Anadys Drug
Sep 10, 2009 Anadys Pharmaceuticals initiates dosing in Phase II hepatitis trial
Sep 09, 2009 Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
Sep 03, 2009 Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
Aug 26, 2009 TheFortuneFinancial.com Free Market Research on AINV, IPCR, ASBC,TTWO, SOLF and ANDS
Aug 13, 2009 BiomedReports: News and FDA Updates for SeraCare (NASDAQ:SRLS), Altus (Nasdaq:ALTU), Anadys (Nasdaq:ANDS), Angiotech (NASDAQ:ANPI)
 
ZACKS COMMENTARY FOR ANDS
Nov 10, 2009 Zacks Equity Research: Report for ANDS
Sep 25, 2009 Zacks Blog: Mid-Stage Study for Anadys Drug
Sep 11, 2009 Zacks Blog: Anadys Begins Mid-Stage Trial
Jul 31, 2009 Zacks Blog: Anadys Reports Narrower Loss
Jul 22, 2009 Zacks Blog: Earnings Preview: Anadys
Jun 04, 2009 Zacks Blog: Anadys Pharma Restructuring
Apr 27, 2009 Zacks Blog: Anadys: Too Early for HCV Drug
Dec 05, 2008 Zacks Analyst Interviews: Biotechnology Industry

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research